GLYC

GlycoMimetics Stock Price

2.88
0.00 (0.0%)
2.88
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
GlycoMimetics Inc GLYC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.88 07:06:40
Close Price Low Price High Price Open Price Previous Close
2.88
Bid Price Ask Price Spread News
2.76 2.92 0.16 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.88 USD

GlycoMimetics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 137.45M 47.72M 25.46M $ - $ - -1.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.70%

more financials information »

GlycoMimetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLYC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.223.392.873.10336,968-0.34-10.56%
1 Month3.073.622.873.28227,742-0.19-6.19%
3 Months3.954.1352.873.48248,774-1.07-27.09%
6 Months2.855.752.553.39617,1020.031.05%
1 Year5.206.721.823.58437,174-2.32-44.62%
3 Years10.9226.051.8210.11478,708-8.04-73.63%
5 Years6.2926.051.8210.73456,022-3.41-54.21%

GlycoMimetics Description

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.


Your Recent History
NASDAQ
GLYC
GlycoMimet..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.